Latest news with #BME
Yahoo
6 hours ago
- Business
- Yahoo
European Growth Companies Insiders Are Backing
The European market has shown tentative optimism amid ongoing trade discussions with the U.S., while the European Central Bank's decision to hold interest rates steady has bolstered the euro. In this context, growth companies with high insider ownership can be particularly appealing, as they often signal confidence from those closest to the company's operations and strategic direction. Top 10 Growth Companies With High Insider Ownership In Europe Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 43.3% MedinCell (ENXTPA:MEDCL) 13.9% 129.3% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 65% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 62.3% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 215 stocks from our Fast Growing European Companies With High Insider Ownership screener. We're going to check out a few of the best picks from our screener tool. CVC Capital Partners Simply Wall St Growth Rating: ★★★★★☆ Overview: CVC Capital Partners plc is a private equity and venture capital firm that focuses on middle market secondaries, infrastructure and credit, management buyouts, leveraged buyouts, growth equity, mature investments, recapitalizations, strip sales, and spinouts with a market cap of €18.24 billion. Operations: The firm's revenue segments include €135.64 million from Credit, €94.99 million from Secondaries, €89.56 million from Infrastructure, and €861.04 million from Private Equity. Insider Ownership: 20.2% Return On Equity Forecast: 47% (2027 estimate) CVC Capital Partners, with substantial insider ownership, is navigating a dynamic landscape marked by strategic ventures and potential acquisitions. Despite a forecasted slower revenue growth of 10.6% annually compared to some higher benchmarks, CVC's earnings are expected to grow significantly at 37.4% per year, surpassing the Dutch market average. Recent M&A activities include exploring significant buyouts like Gland Pharma and Nuvama Wealth Management, showcasing CVC's active pursuit of expansion opportunities despite its high debt levels. Delve into the full analysis future growth report here for a deeper understanding of CVC Capital Partners. Upon reviewing our latest valuation report, CVC Capital Partners' share price might be too optimistic. Moreld Simply Wall St Growth Rating: ★★★★☆☆ Overview: Moreld AS offers integrated solutions for the energy, marine, and industrial sectors both in Norway and internationally, with a market cap of NOK3.65 billion. Operations: The company's revenue is primarily generated from Moreld Apply, contributing NOK4.17 billion, and Global Maritime, adding NOK894.98 million. Insider Ownership: 31.3% Return On Equity Forecast: 50% (2028 estimate) Moreld, with significant insider ownership, is transitioning to a public limited company and listing on Euronext Oslo Børs. Despite a slower revenue growth forecast of 0.9% annually compared to the Norwegian market, earnings are expected to grow by 76.2% per year. The company has initiated share buybacks and declared dividends of NOK 0.42 per share, though current dividends are not well covered by earnings. Moreld aims for profitability within three years, supported by high return on equity projections. Take a closer look at Moreld's potential here in our earnings growth report. Our valuation report unveils the possibility Moreld's shares may be trading at a discount. Friedrich Vorwerk Group Simply Wall St Growth Rating: ★★★★☆☆ Overview: Friedrich Vorwerk Group SE offers solutions for energy transformation and transportation across Germany and Europe, with a market cap of €1.78 billion. Operations: The company's revenue segments include Electricity (€238.20 million), Natural Gas (€173.92 million), Clean Hydrogen (€24.16 million), and Adjacent Opportunities (€118.40 million). Insider Ownership: 18.7% Return On Equity Forecast: 21% (2028 estimate) Friedrich Vorwerk Group, with substantial insider ownership, is experiencing strong growth momentum. Recent major contracts, including the ETL 182 pipeline and SuedLink projects, bolster its revenue prospects. The company raised its 2025 revenue forecast to €610-650 million following robust first-quarter results. Earnings are projected to grow at 17% annually, outpacing the German market average. While revenue growth is slower than some peers at 9.6%, it remains above market expectations, supported by a high return on equity forecast of 20.9%. Get an in-depth perspective on Friedrich Vorwerk Group's performance by reading our analyst estimates report here. The analysis detailed in our Friedrich Vorwerk Group valuation report hints at an inflated share price compared to its estimated value. Next Steps Access the full spectrum of 215 Fast Growing European Companies With High Insider Ownership by clicking on this link. Want To Explore Some Alternatives? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ENXTAM:CVC OB:MORLD and XTRA:VH2. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Business Wire
2 days ago
- Business
- Business Wire
Stonepeak Acquires Interest in Solaria's Generia Land
NEW YORK & MADRID--(BUSINESS WIRE)--Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and Solaria Energía y Medio Ambiente ('Solaria')(BME: SLR), one of Spain's leading renewable independent power producers, today announced that Stonepeak has completed the acquisition of an interest in Solaria's land platform dedicated to renewables, Generia Land, S.L. ('Generia' or 'the Company'). Together, Stonepeak and Solaria will have joint ownership and governance of Generia. Established in 2022, Generia is dedicated to sourcing, acquiring, and leasing land in Europe to renewable energy projects, including solar, wind, and battery storage. The Company has a multi-tenant strategy, sourcing and acquiring land for projects being developed by both Solaria and third-party developers. Generia currently has thousands of hectares of land, primarily in Spain and Italy, and will acquire additional land with Stonepeak's investment. This land will support more than 4 GW of supported renewable energy projects. Stonepeak intends to continue to invest behind Generia's strong near-term pipeline of growth opportunities, which is supported by Solaria's broader goals of developing 18GW of capacity for multiple technologies by 2030. Anthony Borreca, Senior Managing Director and Co-Head of Energy at Stonepeak, said, 'The European energy market is in the midst of an incredible transformation, with renewable generation capacity expected to more than double between 2020 and 2030, and securing land is undoubtedly an essential role in this transition. We view land aggregation as an attractive and downside-protected segment of the value chain, given its propensity for long-term, inflation-linked revenues, with limited power price exposure.' He continued, 'Generia's robust pipeline, coupled with Solaria's established presence in Europe, make it a perfect fit for our newly established independent land aggregation platform, which will look to construct a diversified portfolio of grid-connected sites for critical renewable energy infrastructure across Europe. We look forward to scaling Generia and playing a meaningful role in the development of European renewables over the coming decades.' Arturo Díaz-Tejeiro Larrañaga, Chief Executive Officer of Solaria, added, 'It is a great honor to partner with a top-tier investor like Stonepeak to build one of Europe's leading renewable land platforms. The region offers significant growth potential for these types of investments, supported by strong governmental support for renewable energy and the energy transition. We are confident that Generia will play a key role in securing the land needed to meet the ambitious renewables targets set across Europe.' Terms of the transaction were not disclosed, and the transaction has already closed. Simpson Thacher & Bartlett LLP and Watson, Farley & Williams served as legal counsel to Stonepeak. White & Case LLP served as legal counsel and Alantra and Kutxabank Investment served as financial advisor to Solaria. About Stonepeak Stonepeak is a leading alternative investment firm specializing in infrastructure and real assets with approximately $73 billion of assets under management. Through its investment in defensive, hard-asset businesses globally, Stonepeak aims to create value for its investors and portfolio companies, with a focus on downside protection and strong risk-adjusted returns. Stonepeak, as sponsor of private equity and credit investment vehicles, provides capital, operational support, and committed partnership to grow investments in its target sectors, which include transport and logistics, digital infrastructure, energy and energy transition, and real estate. Stonepeak is headquartered in New York with offices in Houston, Washington, D.C., London, Hong Kong, Seoul, Singapore, Sydney, Tokyo, Abu Dhabi, and Riyadh. For more information, please visit About Solaria Solaria is a leading company in infrastructure, power generation and data centres in Europe. Since its foundation in 2002, it has specialized in renewable energies. Its business model has evolved from the manufacture of photovoltaic cells and panels to the development and management of generation plants. Solaria has a long history on the Spanish stock exchange, where it has been listed since 2007, culminating in 2020 with its entry into the selective Ibex 35. In 2021 Solaria joined the United Nations Global Compact as a Signatory Partner, given the company's firm commitment to sustainability, in line with the Sustainable Development Goals (SDGs) and the 2030 Agenda. In recent years, Solaria has made great efforts to integrate sustainability as a fundamental pillar of its growth strategy. Since 2019, the company has reduced its carbon footprint by 92% and, among other milestones, has set the goal of zero emissions by 2030, through initiatives aimed at energy efficiency. For more information, please visit
Yahoo
2 days ago
- Business
- Yahoo
Lleida.net increases its Q2 2025 EBITDA by 33 percent
Madrid, July 28.- Technology services company (BME: LLN) (EPA: ALLN) (OTCQX: LLEIF) reported EBITDA of €971,000 in the second quarter of 2025, up 33 percent from the same period last year, according to preliminary results presented to the market today. This growth was driven by a significant increase in revenue from certified electronic notification and contracting services, which grew by double digits. During the period, the company's pre-tax profit reached €296,000, up 97 percent from the second quarter of 2024. Overall, the company reported a turnover of 4.84 million euros in the second quarter of 2025, in line with its turnover in the same quarter last year. As of June 30, 2025, the company recorded a cumulative turnover of $10.13 million, representing a six percent increase over the same period last year. Similarly, it recorded a cumulative EBITDA of €2.195 million, showing a 57% increase over the previous year. However, its cumulative pre-tax profit for 2025 has already grown to €937,000, two and a half times higher than that recorded in the summer of 2024. "For another quarter, the company has grown by double digits, with figures that confirm that our current policy, focused on optimizing commercial efforts and strengthening the technology area, is yielding good results," explained Sisco Sapena, CEO and founder of the company. In terms of debt, the company has net financial debt of €6.29 million, down from €7.41 million at the end of 2024. The business line that has grown the most this quarter is certified electronic notification, which increased by 22 percent to €643,000. Similarly, the certified electronic contracting line increased by 15 percent to €904,000. The ICX Wholesale line decreased by eight percent, while the Other SaaS line decreased by 39 percent. The company's SMS solutions also increased by 14 percent to €1.14 million compared to the same quarter last year. Founded in 1995, is one of Europe's leading providers of certification, notification, and registered electronic signature services. The company holds more than 300 patents in over 60 countries, covering the fields of certified electronic notification, contracting, and signatures. Its shares have been traded on BME Growth (Madrid), Euronext Paris, OTCQX in New York, as well as Stuttgart and Frankfurt. Last June, the company became the first BME Growth-listed company to achieve full gender parity on its Board of Directors, following the appointment of four new independent female directors. SAFE HARBOR STATEMENTThis press release contains statements regarding the future of the company and its innovations. Statements regarding the future may be accompanied by words such as "anticipate," "believe," "estimate," "wait," "anticipate," "pretend," "power," "plan," "potential," the use of future time and other terms of similar meaning. No undue reliance should be placed on these claims. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements, including uncertainty of the company's commercial success, ability to protect our intellectual property rights, and other risks. These statements are based on current beliefs and forecasts and refer only to the date of this press release. The company assumes no obligation to publicly update its forward-looking statements, regardless of whether new information, future events or any other circumstances arise. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 days ago
- Business
- Yahoo
3 European Growth Companies With Insider Ownership Seeing Up To 114% Earnings Growth
As European markets navigate a landscape of mixed stock index performances and ongoing trade discussions, investors are keenly observing growth opportunities within the region. In this context, companies with high insider ownership often draw attention due to their potential for alignment between management and shareholder interests, making them intriguing candidates in today's market environment. Top 10 Growth Companies With High Insider Ownership In Europe Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 43.3% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 94.5% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 62.3% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 214 stocks from our Fast Growing European Companies With High Insider Ownership screener. Here's a peek at a few of the choices from the screener. Paratus Energy Services Simply Wall St Growth Rating: ★★★★☆☆ Overview: Paratus Energy Services Ltd. operates through its subsidiaries to provide drilling services with a fleet of jack-up rigs under contracts in Mexico, and it has a market capitalization of NOK6.35 billion. Operations: The company's revenue segments include $205 million from Fontis and $197.80 million from Seagems. Insider Ownership: 30.3% Earnings Growth Forecast: 36.5% p.a. Paratus Energy Services has significant growth potential, with earnings forecasted to grow at 36.5% annually, outpacing the Norwegian market's 10.8%. Despite a decline in Q1 sales and net income compared to last year, the company maintains a high return on equity projection of 96.1% within three years. However, revenue growth is expected to lag behind the market at just 0.9%. The stock trades significantly below its estimated fair value but faces challenges with interest coverage from earnings. Dive into the specifics of Paratus Energy Services here with our thorough growth forecast report. According our valuation report, there's an indication that Paratus Energy Services' share price might be on the cheaper side. Devyser Diagnostics Simply Wall St Growth Rating: ★★★★★☆ Overview: Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing related to hereditary diseases, oncology, and post-transplantation monitoring across multiple regions including Europe, the Middle East, Africa, the Americas, and Asia with a market cap of approximately SEK2.52 billion. Operations: The company's revenue is primarily derived from the sale of diagnostic kits and equipment, amounting to SEK235.10 million. Insider Ownership: 35.4% Earnings Growth Forecast: 115.0% p.a. Devyser Diagnostics shows promising growth potential, with revenue projected to grow at 27.7% annually, significantly outpacing the Swedish market's 5.2%. The company recently reported a turnaround in Q2 earnings, achieving SEK 1.3 million net income compared to a loss last year. Devyser's innovative product launches in genomic blood typing and HLA loss detection bolster its research capabilities and market position. Despite low return on equity forecasts, profitability is expected within three years. Unlock comprehensive insights into our analysis of Devyser Diagnostics stock in this growth report. In light of our recent valuation report, it seems possible that Devyser Diagnostics is trading beyond its estimated value. Surgical Science Sweden Simply Wall St Growth Rating: ★★★★☆☆ Overview: Surgical Science Sweden AB (publ) specializes in developing and marketing virtual reality simulators for evidence-based medical training globally, with a market cap of SEK8.08 billion. Operations: The company generates revenue through two main segments: Industry/OEM, contributing SEK460.22 million, and Educational Products, accounting for SEK486.31 million. Insider Ownership: 14.8% Earnings Growth Forecast: 32.5% p.a. Surgical Science Sweden demonstrates strong growth potential with earnings projected to grow 32.54% annually, outpacing the Swedish market's 16.9%. Recent Q1 results show sales of SEK 250.69 million and net income of SEK 33.24 million, reflecting positive year-over-year growth. Despite a lower profit margin than last year, insider activity remains positive with more shares bought than sold recently. The company trades at a significant discount to its estimated fair value, indicating potential investment appeal amidst board leadership changes. Delve into the full analysis future growth report here for a deeper understanding of Surgical Science Sweden. Our expertly prepared valuation report Surgical Science Sweden implies its share price may be too high. Turning Ideas Into Actions Click through to start exploring the rest of the 211 Fast Growing European Companies With High Insider Ownership now. Ready To Venture Into Other Investment Styles? Outshine the giants: these 20 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include OB:PLSV OM:DVYSR and OM:SUS. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
5 days ago
- Business
- Yahoo
European Growth Companies With High Insider Ownership To Watch
As the European markets navigate a landscape of mixed stock index performances and ongoing trade discussions with the U.S., investors are keenly observing economic indicators such as inflation and industrial output. In this environment, growth companies with substantial insider ownership can be particularly appealing, as they often signal strong internal confidence and alignment of interests between management and shareholders. Top 10 Growth Companies With High Insider Ownership In Europe Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 43.3% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 94.5% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 62.3% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 214 stocks from our Fast Growing European Companies With High Insider Ownership screener. Here's a peek at a few of the choices from the screener. PostNL Simply Wall St Growth Rating: ★★★★☆☆ Overview: PostNL N.V. offers postal and logistics services to businesses and consumers in the Netherlands, Europe, and internationally, with a market cap of €536.66 million. Operations: The company's revenue is primarily derived from its Parcels segment, generating €2.39 billion, and the Mail in The Netherlands segment, contributing €1.33 billion. Insider Ownership: 35.1% Earnings Growth Forecast: 32.9% p.a. PostNL is experiencing significant earnings growth, forecasted at 32.88% annually, outpacing the Dutch market's 9.1%. Despite a recent net loss of €17 million for Q1 2025, this marks an improvement from the previous year's €20 million loss. However, revenue growth remains modest at 1.9% per year and below the market average of 7.3%. The company faces challenges with high debt levels and volatile share prices but trades significantly below its estimated fair value. Delve into the full analysis future growth report here for a deeper understanding of PostNL. Upon reviewing our latest valuation report, PostNL's share price might be too optimistic. Medicover Simply Wall St Growth Rating: ★★★★★☆ Overview: Medicover AB (publ) offers healthcare and diagnostic services in Poland, Sweden, and internationally, with a market cap of SEK43.03 billion. Operations: The company's revenue segments include healthcare services at €1.17 billion and diagnostic services at €0.80 billion. Insider Ownership: 11.2% Earnings Growth Forecast: 23.5% p.a. Medicover shows strong growth potential, with earnings forecasted to grow significantly at 23.5% annually, surpassing the Swedish market's average. Recent earnings reports highlight a substantial increase in net income and revenue for the first half of 2025. Despite no substantial insider buying recently, insider transactions have been more purchases than sales. Medicover's innovative MRD assay development marks a promising advancement in personalized cancer treatment, potentially enhancing its market position and supporting future growth prospects. Take a closer look at Medicover's potential here in our earnings growth report. Our expertly prepared valuation report Medicover implies its share price may be too high. Yubico Simply Wall St Growth Rating: ★★★★★☆ Overview: Yubico AB offers authentication solutions for computers, networks, and online services with a market cap of SEK12 billion. Operations: The company's revenue primarily comes from its Security Software & Services segment, totaling SEK2.45 billion. Insider Ownership: 36.5% Earnings Growth Forecast: 23.9% p.a. Yubico demonstrates strong growth potential with earnings expected to grow significantly at 23.9% annually, outpacing the Swedish market. Recent expansions, including YubiKey as a Service in the EU and increased delivery coverage, enhance its market reach and operational efficiency against phishing threats. Despite a decline in net income for Q1 2025, insider buying has been substantial recently, indicating confidence in future prospects. The company trades at good value compared to peers within the industry. Click to explore a detailed breakdown of our findings in Yubico's earnings growth report. Upon reviewing our latest valuation report, Yubico's share price might be too pessimistic. Where To Now? Click here to access our complete index of 214 Fast Growing European Companies With High Insider Ownership. Want To Explore Some Alternatives? This technology could replace computers: discover the 27 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ENXTAM:PNL OM:MCOV B and OM:YUBICO. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
